The global Viscosupplementation Market is witnessing significant growth as healthcare providers increasingly adopt minimally invasive therapies for managing osteoarthritis and other joint disorders. Viscosupplementation involves injecting hyaluronic acid into affected joints to improve lubrication, reduce pain, and enhance mobility, offering patients an effective alternative to surgery. Rising cases of knee osteoarthritis, an aging global population, growing awareness of non-surgical treatment options, and continuous advancements in injectable therapies are driving strong market momentum.
According to the latest market assessment, the global viscosupplementation market was valued at USD 5.86 billion in 2025 and is projected to grow from USD 6.39 billion in 2026 to USD 12.69 billion by 2034, registering a CAGR of 8.96% during the forecast period (2026–2034). Increasing investments in orthopedic care, expanding healthcare access, and growing adoption of advanced viscosupplementation products are expected to sustain long-term market growth.
Base Year and Forecast Overview
- Base Year: 2025
- Historical Period: 2022–2024
- Forecast Period: 2026–2034
- Market Size (2025): USD 5.86 Billion
- Market Size (2026): USD 6.39 Billion
- Projected Market Size (2034): USD 12.69 Billion
- CAGR: 8.96% during the forecast period
Key Highlights
- North America held the largest share of the global viscosupplementation market.
- Asia-Pacific is expected to witness the fastest growth during the forecast period.
- Single-Injection Viscosupplementation represented the largest product segment.
- Hospitals and Orthopedic Clinics accounted for both the largest and fastest-growing end-user segment.
- Increasing demand for minimally invasive orthopedic treatments and improved hyaluronic acid formulations continues to support market expansion.
Market Dynamics
Rising Osteoarthritis Burden and Preference for Minimally Invasive Therapies Drive Market Growth
The growing prevalence of osteoarthritis, particularly among aging populations and individuals with obesity, is significantly increasing demand for viscosupplementation therapies worldwide. Patients and physicians are increasingly choosing hyaluronic acid injections to relieve joint pain, improve mobility, and delay surgical interventions such as knee replacement. The treatment offers shorter recovery times and supports improved quality of life, making it an attractive option for long-term disease management.
Healthcare providers are also expanding access to orthopedic services while manufacturers continue introducing advanced formulations with longer-lasting therapeutic benefits. Growing awareness regarding early osteoarthritis management and increasing healthcare expenditure are further contributing to market expansion.
Treatment Costs Present Challenges While Innovation Creates New Growth Opportunities
Although viscosupplementation has gained widespread clinical acceptance, treatment costs, reimbursement limitations, and varying clinical guidelines across different countries continue to present challenges for broader market adoption. In addition, patient response may vary depending on disease severity and individual clinical conditions.
Despite these challenges, ongoing research into next-generation hyaluronic acid products, combination therapies, regenerative medicine, and personalized orthopedic treatments is creating promising opportunities for industry participants. Increasing investments in musculoskeletal healthcare and technological innovation are expected to strengthen market growth over the forecast period.
Top Market Players
- Sanofi S.A.
- Anika Therapeutics Inc.
- Ferring Pharmaceuticals
- Zimmer Biomet Holdings Inc.
- Bioventus Inc.
- Seikagaku Corporation
- Fidia Farmaceutici S.p.A.
- Chugai Pharmaceutical Co., Ltd.
- Lifecore Biomedical
- TRB Chemedica International SA
- LG Chem Ltd.
- OrthogenRx Inc.
Market Segmentation
By Product Type
- Single-Injection Viscosupplementation
- Three-Injection Viscosupplementation
- Five-Injection Viscosupplementation
By Application
- Knee Osteoarthritis
- Hip Osteoarthritis
- Shoulder Osteoarthritis
- Others
By End User
- Hospitals
- Orthopedic Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Unlock Full Report Insights and Strategic Analysis -https://straitsresearch.com/report/viscosupplementation-market
The report delivers comprehensive insights into market size, regional trends, competitive landscape, technological advancements, product innovations, regulatory developments, strategic collaborations, investment opportunities, company profiles, and future growth prospects. It serves as a valuable business resource for pharmaceutical companies, orthopedic device manufacturers, healthcare providers, investors, and industry stakeholders seeking to strengthen their presence in the rapidly growing global viscosupplementation market.
About Us
Straits Research is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports.
Contact Us
Email: sales@straitsresearch.com
Tel: +1 646 905 0080 (U.S.), +44 203 695 0070 (U.K.)
Comments